Fingerprint
Dive into the research topics of 'CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer
A. Rum Yoon, Soyeon Lee, Ju Hee Kim, Yejin Park, Taeyoung Koo, Chae Ok Yun
Research output: Contribution to journal › Article › peer-review